Apollon Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$343K	Buy	1,367 +396	+41%	+$98.5K	0.01%	1044
2025 Q4	$267K	Buy	971 +96	+11%	+$26.3K	﹤0.01%	1109
2025 Q3	$230K	Sell	875 -160	-15%	-$38.9K	﹤0.01%	1167
2025 Q2	$226K	Sell	1,035 -286	-22%	-$61.1K	﹤0.01%	1126
2025 Q1	$296K	Buy	1,321 +126	+11%	+$34.7K	0.01%	959
2024 Q4	$391K	Sell	1,195 -67	-5%	-$21.1K	0.01%	845
2024 Q3	$379K	Buy	1,262 +1	+0.1%	+$306	0.01%	826
2024 Q2	$415K	Sell	1,261 -126	-9%	-$44.5K	0.01%	751
2024 Q1	$549K	Sell	1,387 -163	-11%	-$60.3K	0.02%	662
2023 Q4	$546K	Sell	1,550 -74	-5%	-$26.2K	0.02%	625
2023 Q3	$609K	Buy	1,624 +296	+22%	+$114K	0.03%	496
2023 Q2	$508K	Sell	1,328 -1,678	-56%	-$599K	0.02%	585
2023 Q1	$1.04M	Sell	3,006 -323	-10%	-$94.4K	0.06%	315
2022 Q4	$784K	Buy	3,329 +1,001	+43%	+$237K	0.06%	370
2022 Q3	$573K	Buy	2,328 +257	+12%	+$78.3K	0.05%	409
2022 Q2	$626K	Buy	2,071 +448	+28%	+$146K	0.05%	375
2022 Q1	$667K	Buy	1,623 +175	+12%	+$68.5K	0.05%	382
2021 Q4	$679K	Buy	1,448 +50	+4%	+$21.5K	0.05%	393
2021 Q3	$594K	Sell	1,398 -361	-21%	-$152K	0.08%	236
2021 Q2	$632K	Buy	+1,759	New	+$581K	0.11%	189